SEARCH RESULTS FOR:

George Ankomah

PARTNER, DELOITTE GHANA
"Deloitte is a key stakeholder to the industry, providing input in the development of various mining laws over the years."

Adama Soro

PRESIDENT, CHAMBER OF MINES BURKINA FASO
"Companies like Endeavour Mining, IAMGOLD, Orezone, Trevali or Roxgold (Fortuna Silver Mines) and many others, continue to invest in the country, adding their vote of confidence in the potential of Burkina Faso."

Craig Roberts

CEO, NEW FOUND GOLD
Newfoundland and Labrador Mining 2021
"We have eight drills currently running and may expand this further to accelerate drill testing of a very large prospective target area."

David Christie

PRESIDENT AND CEO, ORFORD MINING
"When you look at Orford, it has potential for multiple discoveries on a massive land position in what we think is a new gold district."

Rahul Paul

PRESIDENT AND INTERIM CEO, RADISSON MINING RESOURCES
"We are located in elephant country, with a number of large producers within 70 km of O’Brien."

David Russell

PRESIDENT AND CEO, GALLEON GOLD CORP.
"Galleon Gold has a significant land package in a great district that has amazing infrastructure for mining."

Doug Ramshaw

PRESIDENT, MINERA ALAMOS
"Minera Alamos is now at the far peak of the curve, which is a great differentiator as very few explorers and developers get to be producers."

Gil Roth

PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
"The pandemic highlighted the key role that CDMOs play, and we need a voice to drive consensus internally, face regulators, and ensure we have a seat at the table."

Adolfo Vera

PRESIDENTE y CEO, SOUTHERN PEAKS MINING
Southern Peaks Mining shares the company’s latest developments at its Condestable and Ariana projects in Peru (Spanish interview)

Gianflavio Carozzi

CEO, AESA
Underground contractor AESA has formed a JV with Redpath for Newmont’s Yanacocha Sulfides project (Spanish interview)

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS